New drug approvals and a federal dementia care pilot program among the year's significant developments, according to the nonprofit.

A common cognitive disorder with symptoms that mimic Alzheimer's is often mistaken for the disease. Researchers are calling for criteria to diagnose the little-known condition.

Huge pressure' The report from Dr Brink said the island needed to focus on preventing illnesses as well as treating them. Mrs Thompson said high low-density lipoprotein cholester

People who care for patients with Alzheimer's or other dementia must be alert when winter weather turns dangerous, advises the Nebraska Alzheimer's Association.

Alzheimer’s Association will be hosting a series of classes in Lawton but since their last announcement of classes, they have released an update on their class schedule.

New guidelines will help doctors identify patients with a common memory-loss syndrome that is often misdiagnosed as Alzheimer's disease in older adults. The diagnostic criteria for limbic-predominant age-related TDP-43 encephalopathy (LATE) have just been published.

Dementia cases in the U.S. are expected to double by 2060, with an estimated one million people diagnosed per year, according to a new study led by Johns Hopkins University and other institutions. Researchers found that Americans’ risk of developing ...

A new study clams dementia cases will double by 2060. Here’s what experts believe could be driving the rise in dementia rates and what you can do to help prevent it.

Across Iowa, 11% of people, 65 or older, have Alzheimer's. That number is even higher in rural counties. Here's how you can get support, with a virtual forum.

Broad classes of drugs, including antibiotics, antivirals, vaccines, anti-inflammatories and antihypertensives, were associated with a lower risk for dementia in a large analysis.

Some antibiotics, antivirals, vaccinations and anti-inflammatory medications are linked to a reduced risk of dementia, a  study shows. The report was published Tuesday in Alzheimer’s & Dementia.

Early research suggests GLP-1 drugs could prevent or treat Alzheimer's Disease. Results from a big clinical trial could soon confirm that.